FutureMeds

Lodz 91-363

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Hypertriglyceridemia, Primary Sjogrens Disease

Studies at this site

• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed